ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,190Medicare Part D Prescriptions Filled, Including Refills

Rank: 132 out of 2715

$650K Total Retail Price of All Prescriptions

Rank: 205 out of 2715

454 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 679 633 113 1 4
FUROSEMIDE 498 493* 77 2 8
LISINOPRIL 389 365 89 3 3
HYDROCODONE-ACETAMINOPHEN 347 282 77 S3 4 1
OMEPRAZOLE 339 308 70 5 5
POTASSIUM CHLORIDE 284 279* 35 6 19
WARFARIN SODIUM 250 245* 32 7 18
SIMVASTATIN 239 234* 53 8 2
METOPROLOL TARTRATE 235 204 49 9 10
METFORMIN HCL 231 200 50 10 7
SERTRALINE HCL 221 207 34 11 23
ATORVASTATIN CALCIUM 213 195 43 12 9
CITALOPRAM HBR 198 149 37 13 22
CLOPIDOGREL 196 184 32 14 21
IPRATROPIUM-ALBUTEROL 188 188 30 15 140
LANTUS 177 106 20 16 60
MIRTAZAPINE 168 163* 33 17 62
GABAPENTIN 154 135 17 18 14
POLYETHYLENE GLYCOL 3350 148 143* 45 19 59
CARVEDILOL 143 143 26 20 25
FINASTERIDE 143 114 23 20 96
SPIRONOLACTONE 133 121 27 22 74
TAMSULOSIN HCL 119 101 23 23 26
LOSARTAN POTASSIUM 118 113* 28 24 17
AMLODIPINE BESYLATE 116 111* 23 25 6
CARBIDOPA-LEVODOPA 110 110 13 26 119
DIGOXIN 94 89* 20 27 163
QUETIAPINE FUMARATE 88 <11 <11 A 28 56
FENTANYL 85 73 21 S2 29 53
METOPROLOL SUCCINATE 84 67 17 30 20
NAMENDA 83 <11 <11 31 37
RISPERIDONE 80 <11 <11 A 32 80
LEVETIRACETAM 79 <11 <11 33 99
ZETIA 79 46 14 33 87
NOVOLOG 78 <11 <11 35 122
DONEPEZIL HCL 72 72 12 36 33
GEMFIBROZIL 70 55 13 37 104
ALENDRONATE SODIUM 69 64* 15 38 38
ISOSORBIDE MONONITRATE ER 68 68 13 39 43
VENLAFAXINE HCL ER 67 62* 13 40 101
PRAVASTATIN SODIUM 66 61* 18 41 16
NIFEDICAL XL 65 <11 <11 42 228
METOCLOPRAMIDE HCL 63 58* 24 43 206
ATENOLOL 62 57* 16 44 13
ALLOPURINOL 61 56* 15 45 34
LOVASTATIN 61 48 14 45 32
SUCRALFATE 60 55* 13 47 205
PAROXETINE HCL 60 42 12 47 73
AMITRIPTYLINE HCL 59 45 11 R 49 92
VENLAFAXINE HCL 58 53* 13 50 236
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 52* 24 51 90
ACETAMINOPHEN-CODEINE 56 51* 15 S3 52 69
OLANZAPINE 54 <11 <11 A 53 129
BACLOFEN 54 <11 <11 53 109
LEVEMIR 53 <11 <11 55 161
COLCRYS 50 <11 <11 56 226
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.